Daniel R. Gomez

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez, Chad Tang, Jianjun Zhang et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Daniel R. Gomez, George R. Blumenschein, J. Jack Lee et al. · The Lancet Oncology · 2016 · 1.1K citations · Full text

First-line Systemic Therapy, Medicine, Cancer Management +9

PDL1 Regulation by p53 via miR-34

María Angélica Cortez, Cristina Ivan, David R. Valdecanas et al. · JNCI Journal of the National Cancer Institute · 2015 · 657 citations · Full text

Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes

Chad Tang, Zhongxing Liao, Daniel R. Gomez et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 360 citations

Lymphopenia Association, Medicine, Lung V5 +10

Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer

Everett J. Moding, Yufei Liu, Barzin Y. Nabet et al. · Nature Cancer · 2020 · 357 citations · Full text